Barclays PLC Sanofi Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Sanofi stock. As of the latest transaction made, Barclays PLC holds 639,772 shares of SNY stock, worth $31.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

639,772

Previous 639,772 -0.0%

Holding current value

$31.2 Million

Previous $36.9 Million -0.0%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$48.54 - $58.53 $16.1 Million - $19.4 Million	331,445 Added 107.5%	639,772 $36.9 Million
Q2 2024 Aug 14, 2024	SELL	$45.39 - $50.36 $7.86 Million - $8.72 Million	-173,131 Reduced 35.96%	308,327 $15 Million
Q1 2024 May 15, 2024	BUY	$45.75 - $52.48 $12.6 Million - $14.4 Million	274,389 Added 132.51%	481,458 $23.4 Million
Q4 2023 Feb 15, 2024	BUY	$43.13 - $54.79 $900,381 - $1.14 Million	20,876 Added 11.21%	207,069 $10.3 Million
Q3 2023 Nov 07, 2023	BUY	$50.95 - $55.2 $3.48 Million - $3.77 Million	68,329 Added 57.97%	186,193 $9.99 Million
Q2 2023 Aug 03, 2023	SELL	$50.45 - $57.18 $4.36 Million - $4.94 Million	-86,338 Reduced 42.28%	117,864 $6.35 Million
Q1 2023 May 04, 2023	SELL	$45.86 - $54.45 $3.25 Million - $3.86 Million	-70,941 Reduced 25.78%	204,202 $11.1 Million
Q4 2022 Feb 13, 2023	SELL	$38.86 - $48.55 $1.55 Million - $1.93 Million	-39,791 Reduced 12.63%	275,143 $13.3 Million
Q3 2022 Nov 03, 2022	SELL	$37.22 - $100.5 $1.62 Million - $4.38 Million	-43,629 Reduced 12.17%	314,934 $12 Million
Q2 2022 Aug 12, 2022	BUY	$48.99 - $57.46 $10.9 Million - $12.8 Million	223,305 Added 165.1%	358,563 $17.9 Million
Q1 2022 May 16, 2022	BUY	$48.48 - $53.65 $3.43 Million - $3.8 Million	70,757 Added 109.7%	135,258 $6.95 Million
Q4 2021 Feb 14, 2022	SELL	$47.07 - $52.35 $2.87 Million - $3.19 Million	-60,907 Reduced 48.57%	64,501 $3.23 Million
Q3 2021 Nov 09, 2021	BUY	$47.89 - $53.12 $2.53 Million - $2.81 Million	52,816 Added 72.76%	125,408 $6.05 Million
Q2 2021 Aug 13, 2021	BUY	$49.36 - $54.25 $938,185 - $1.03 Million	19,007 Added 35.47%	72,592 $3.82 Million
Q1 2021 May 13, 2021	SELL	$45.46 - $50.51 $2.56 Million - $2.85 Million	-56,341 Reduced 51.25%	53,585 $2.65 Million
Q4 2020 Feb 11, 2021	SELL	$45.3 - $51.62 $7.51 Million - $8.56 Million	-165,804 Reduced 60.13%	109,926 $5.34 Million
Q3 2020 Nov 12, 2020	SELL	$49.47 - $53.77 $4.84 Million - $5.27 Million	-97,920 Reduced 26.21%	275,730 $13.8 Million
Q2 2020 Aug 12, 2020	BUY	$42.91 - $52.5 $8.5 Million - $10.4 Million	198,084 Added 112.83%	373,650 $19.1 Million
Q1 2020 May 13, 2020	BUY	$38.02 - $51.66 $4.78 Million - $6.5 Million	125,807 Added 252.83%	175,566 $7.68 Million
Q4 2019 Feb 10, 2020	BUY	$44.25 - $50.86 $1.68 Million - $1.93 Million	37,984 Added 322.58%	49,759 $2.5 Million
Q3 2019 Nov 14, 2019	SELL	$40.34 - $46.64 $10.9 Million - $12.6 Million	-269,238 Reduced 95.81%	11,775 $546,000
Q2 2019 Aug 14, 2019	BUY	$40.43 - $44.3 $8.57 Million - $9.39 Million	211,958 Added 306.94%	281,013 $12.2 Million
Q1 2019 May 15, 2019	SELL	$40.83 - $45.43 $1.81 Million - $2.01 Million	-44,334 Reduced 39.1%	69,055 $3.06 Million
Q4 2018 Feb 14, 2019	SELL	$41.48 - $45.59 $2.45 Million - $2.69 Million	-59,073 Reduced 34.25%	113,389 $4.92 Million
Q3 2018 Nov 14, 2018	SELL	$40.0 - $44.84 $10.9 Million - $12.3 Million	-273,544 Reduced 61.33%	172,462 $7.7 Million
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $7.7 Million - $8.44 Million	204,737 Added 84.86%	446,006 $17.8 Million
Q1 2018 May 15, 2018	BUY	$38.98 - $45.76 $416,657 - $489,128	10,689 Added 4.64%	241,269 $9.67 Million
Q4 2017 Feb 14, 2018	BUY	$42.86 - $50.61 $3.56 Million - $4.2 Million	82,988 Added 56.23%	230,580 $9.91 Million
Q3 2017 Nov 14, 2017	BUY	$47.04 - $50.34 $6.94 Million - $7.43 Million	147,592	147,592 $7.35 Million

Others Institutions Holding SNY

# of Institutions

822

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $122B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account